FDA Drug Recalls

Recalls / Class II

Class IID-0624-2025

Product

Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61

Brand name
Sulfamethoxazole And Trimethoprim
Generic name
Sulfamethoxazole And Trimethoprim
Active ingredients
Sulfamethoxazole, Trimethoprim
Route
Oral
NDC
0904-2725
FDA application
ANDA076899
Affected lot / code info
Lot # N02309, Exp 03/31/2027

Why it was recalled

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Recalling firm

Firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Manufacturer
Major Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
341 Mason Rd, N/A, La Vergne, Tennessee 37086-3606

Distribution

Quantity
N/A
Distribution pattern
USA Nationwide.

Timeline

Recall initiated
2025-09-02
FDA classified
2025-09-10
Posted by FDA
2025-09-17
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0624-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Sulfamethoxazole And Trimethoprim · FDA Drug Recalls